Tyra Biosciences, Inc. TYRA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $111.43M+26.9% | $102.93M+28.5% | $96.92M+23.4% | $94.15M+25.3% | $87.84M+26.7% | ||
| $31.48M+21.6% | $29.83M+23.7% | $29.07M+35.1% | $27.5M+35.4% | $25.89M+39.1% | ||
| $142.91M+25.7% | $132.76M+27.4% | $125.99M+25.9% | $121.65M+27.4% | $113.73M+29.3% | ||
| $142.91M+25.7% | $132.76M+27.4% | $125.99M+25.9% | $121.65M+27.4% | $113.73M+29.3% | ||
| -$142.91M-25.7% | -$132.76M-27.4% | -$125.99M-25.9% | -$121.65M-27.4% | -$113.73M-29.3% | ||
| $11.81M-31.7% | $12.82M-27.7% | $14.31M-12.5% | $15.82M+8.5% | $17.29M+38.5% | ||
| $11.81M-31.7% | $12.82M-27.7% | $14.31M-12.5% | $15.82M+8.5% | $17.29M+38.5% | ||
| -$131.11M-36.0% | -$119.95M-38.7% | -$111.68M-33.4% | -$105.83M-30.9% | -$96.44M-27.8% | ||
| -$2.17-33.1% | -$2.00-32.5% | -$1.87-16.1% | -$1.78-5.3% | -$1.63+3.0% | ||
| -$2.17-33.1% | -$2.00-32.5% | -$1.87-16.1% | -$1.78-5.3% | -$1.63+3.0% | ||
| 240.6M+2.8% | 238.2M+4.9% | 235.8M+11.0% | 235M+19.6% | 234.1M+29.8% | ||
| 240.6M+2.8% | 238.2M+4.9% | 235.8M+11.0% | 235M+19.6% | 234.1M+29.8% | ||
| -$131.69M-37.5% | -$120.32M-39.8% | -$112.99M-37.8% | -$105.21M-29.8% | -$95.74M-26.9% | ||
| $11.81M-31.7% | $12.82M-27.7% | $14.31M-12.5% | $15.82M+8.5% | $17.29M+38.5% | ||
| -$142.91M-25.7% | -$132.76M-27.4% | -$125.99M-25.9% | -$121.65M-27.4% | -$113.73M-29.3% | ||
| -$142.37M-25.8% | -$132.22M-27.5% | -$125.43M-25.9% | -$121.1M-27.4% | -$113.19M-29.3% | ||
| -$142.37M-25.8% | -$132.22M-27.5% | -$125.43M-25.9% | -$121.1M-27.4% | -$113.19M-29.3% | ||
| -$142.91M-25.7% | -$132.76M-27.4% | -$125.99M-25.9% | -$121.65M-27.4% | -$113.73M-29.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Tyra Biosciences, Inc. profitable?
- Tyra Biosciences, Inc. is not currently profitable: it reported a net loss of $131.1M over the trailing twelve months.
- What is Tyra Biosciences, Inc.'s earnings per share?
- Tyra Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-2.17.
- Where does Tyra Biosciences, Inc.'s income statement data come from?
- Every line is extracted from Tyra Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.